Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis b vaccine (recombinant) (Juvic Life Sciences)
- Development stage
- Approved
- Lead developer
- Juvaris BioTherapeutics
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
JuvImmune is a recombinant DNA vaccine indicated for active immunization against infection caused by all known subtypes of the hepatitis B virus (HBV). The vaccine contains purified hepatitis B surface antigen (HBsAg), which is produced by recombinant DNA technology in *Saccharomyces cerevisiae* (yeast) cells. By introducing the HBsAg into the body, JuvImmune stimulates the immune system to produce specific neutralizing antibodies (anti-HBs) that provide long-term protection against the virus. It is primarily used to prevent hepatitis B and its associated chronic conditions, such as liver cirrhosis and hepatocellular carcinoma, and is typically administered via intramuscular injection in a multi-dose schedule.
- Brand names
- JuvImmune
- Other names
- Hepatitis B surface antigen vaccineHBsAg vaccineHepatitis B Vaccine (rDNA) IP
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis b vaccine (recombinant) (Juvic Life Sciences).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis b vaccine (recombinant) (Juvic Life Sciences).